Entire Transcript in Adobe Acrobat Format - National Reference ...

20
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
meeting, not yesterday's but the previous meeting, we had
suggested that there was no distinction between the
clinically relevant and the research but I would stand
corrected. We have all the permutations here.
DR. GREIDER: My recollection was that was true
for the previously collected samples but not for the future
samples and maybe other people can let me know if -- other
subcommittee members.
DR. EMANUEL: Your recollection is this.
(Slide.)
DR. GREIDER: Correct.
DR. EMANUEL: My recollection is at the very
end of the previous meeting was that Steve Holtzman -- we
had suggested -- well, we can go through it because the
suggestion is that the distinctions here, the
recommendations we are going to make are going to be no
different and, therefore, should be collapsed but this is a
work in progress.
DR. COX: Zeke, I would say at least --
although I was not at the meeting but having read things,
the logic, the exact arguments that you make for collapsing
them in the prospective or in the retrospective for me fit
for the prospective too because if you can collapse them
for the retrospective then why can't you collapse them for